☰

Dominic Paquin-Proulx - Publications

Affiliations: 
Walter Reed Army Institute of Research, Silver Spring, MD, United States 
 Laval University, Quebec, Ville de Québec, Québec, Canada 
 Karolinska Institute, Stockholm, Sweden 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 N'guessan KF, Machmach K, Swafford I, Costanzo MC, Wieczorek L, Kim D, Akapirat S, Polonis VR, Pitisuttithum P, Nitayaphan S, Gurunathan S, Sinangil F, Chariyalertsak S, Ake JA, O'connell RJ, ... ... Paquin-Proulx D, et al. Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production. Frontiers in Immunology. 15: 1339727. PMID 38420129 DOI: 10.3389/fimmu.2024.1339727  0.418
2024 Sankhala RS, Lal KG, Jensen JL, Dussupt V, Mendez-Rivera L, Bai H, Wieczorek L, Mayer SV, Zemil M, Wagner DA, Townsley SM, Hajduczki A, Chang WC, Chen WH, Donofrio GC, ... ... Paquin-Proulx D, et al. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques. Nature Communications. 15: 200. PMID 38172512 DOI: 10.1038/s41467-023-44265-0  0.833
2023 Sankhala RS, Dussupt V, Chen WH, Bai H, Martinez EJ, Jensen JL, Rees PA, Hajduczki A, Chang WC, Choe M, Yan L, Sterling SL, Swafford I, Kuklis C, Soman S, ... ... Paquin-Proulx D, et al. Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain. Structure (London, England : 1993). PMID 38157856 DOI: 10.1016/j.str.2023.11.015  0.734
2023 Bissa M, Galli V, Schifanella L, Vaccari M, Rahman MA, Gorini G, Binello N, Sarkis S, Gutowska A, Silva de Castro I, Doster MN, Moles R, Ferrari G, Shen X, Tomaras GD, ... ... Paquin-Proulx D, et al. In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4 T-Cells. Vaccines. 11. PMID 38005994 DOI: 10.3390/vaccines11111662  0.529
2023 Li Y, Merbah M, Wollen-Roberts S, Beckman B, Mdluli T, Curtis DJ, Currier JR, Mendez-Rivera L, Dussupt V, Krebs SJ, De La Barrera R, Michael NL, Paquin-Proulx D, Eller MA, Koren MA, et al. Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine. Ebiomedicine. 97: 104815. PMID 37793212 DOI: 10.1016/j.ebiom.2023.104815  0.568
2023 Gromowski GD, Cincotta CM, Mayer S, King J, Swafford I, McCracken MK, Coleman D, Enoch J, Storme C, Darden J, Peel S, Epperson D, McKee K, Currier JR, Okulicz J, ... Paquin-Proulx D, et al. Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military population. Ebiomedicine. 94: 104683. PMID 37413891 DOI: 10.1016/j.ebiom.2023.104683  0.785
2023 Shubin Z, Stanfield-Oakley S, Puangkaew J, Pitisutthithum P, Nitayaphan S, Gurunathan S, Sinangil F, Chariyalertsak S, Phanuphak N, Ake JA, O'connell RJ, Vasan S, Akapirat S, Eller MA, Ferrari G, ... Paquin-Proulx D, et al. Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector functions magnitude but not durability. Aids (London, England). PMID 37260254 DOI: 10.1097/QAD.0000000000003611  0.555
2023 Rahman MA, Becerra-Flores M, Patskovsky Y, Silva de Castro I, Bissa M, Basu S, Shen X, Williams LD, Sarkis S, N'guessan KF, LaBranche C, Tomaras GD, Aye PP, Veazey R, Paquin-Proulx D, et al. Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV acquisition in macaques. Frontiers in Immunology. 14: 1139402. PMID 37153584 DOI: 10.3389/fimmu.2023.1139402  0.537
2023 Stamos JD, Rahman MA, Gorini G, Silva de Castro I, Becerra-Flores M, Van Wazer DJ, N'Guessan KF, Clark NM, Bissa M, Gutowska A, Mason RD, Kim J, Rao M, Roederer M, Paquin-Proulx D, et al. Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIV Acquisition. Journal of Virology. e0186422. PMID 36976017 DOI: 10.1128/jvi.01864-22  0.497
2023 Shrivastava S, Carmen JM, Lu Z, Basu S, Sankhala RS, Chen WH, Nguyen P, Chang WC, King J, Corbitt C, Mayer S, Bolton JS, Anderson A, Swafford I, Terriquez GD, ... ... Paquin-Proulx D, et al. SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies. Npj Vaccines. 8: 43. PMID 36934088 DOI: 10.1038/s41541-023-00638-6  0.805
2023 Chen WH, Hajduczki A, Martinez EJ, Bai H, Matz H, Hill TM, Lewitus E, Chang WC, Dawit L, Peterson CE, Rees PA, Ajayi AB, Golub ES, Swafford I, Dussupt V, ... ... Paquin-Proulx D, et al. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity. Nature Communications. 14: 580. PMID 36737435 DOI: 10.1038/s41467-023-36106-x  0.793
2022 Yu J, Thomas PV, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Martinez EJ, Chen WH, Sciacca M, Hachmann NP, Lifton M, Miller J, Powers OC, Hall K, ... ... Paquin-Proulx D, et al. Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN. Science Advances. 8: eade4433. PMID 36417525 DOI: 10.1126/sciadv.ade4433  0.798
2022 Li Y, Merbah M, Wollen-Roberts S, Beckman B, Mdluli T, Swafford I, Mayer SV, King J, Corbitt C, Currier JR, Liu H, Esber A, Pinyakorn S, Parikh A, Francisco LV, ... ... Paquin-Proulx D, et al. Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand. Emerging Infectious Diseases. 28. PMID 36220131 DOI: 10.3201/eid2811.221041  0.769
2022 Johnston SC, Ricks KM, Lakhal-Naouar I, Jay A, Subra C, Raymond JL, King HAD, Rossi F, Clements TL, Fetterer D, Tostenson S, Cincotta CM, Hack HR, Kuklis C, Soman S, ... ... Paquin-Proulx D, et al. A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model. Vaccines. 10. PMID 35632473 DOI: 10.3390/vaccines10050717  0.82
2021 Joyce MG, King HAD, Elakhal-Naouar I, Ahmed A, Peachman KK, Macedo Cincotta C, Subra C, Chen RE, Thomas PV, Chen WH, Sankhala RS, Hajduczki A, Martinez EJ, Peterson CE, Chang WC, ... ... Paquin-Proulx D, et al. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Science Translational Medicine. eabi5735. PMID 34914540 DOI: 10.1126/scitranslmed.abi5735  0.805
2021 Dussupt V, Sankhala RS, Mendez-Rivera L, Townsley SM, Schmidt F, Wieczorek L, Lal KG, Donofrio GC, Tran U, Jackson ND, Zaky WI, Zemil M, Tritsch SR, Chen WH, Martinez EJ, ... ... Paquin-Proulx D, et al. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations. Nature Immunology. PMID 34716452 DOI: 10.1038/s41590-021-01068-z  0.765
2021 Wuertz KM, Barkei EK, Chen WH, Martinez EJ, Lakhal-Naouar I, Jagodzinski LL, Paquin-Proulx D, Gromowski GD, Swafford I, Ganesh A, Dong M, Zeng X, Thomas PV, Sankhala RS, Hajduczki A, et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge. Npj Vaccines. 6: 129. PMID 34711815 DOI: 10.1038/s41541-021-00392-7  0.823
2021 King HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, Cincotta CM, Subra C, Peachman KK, Hack HR, Chen RE, Thomas PV, Chen WH, Sankhala RS, Hajduczki A, Martinez EJ, Peterson CE, ... ... Paquin-Proulx D, et al. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34470866 DOI: 10.1073/pnas.2106433118  0.848
2021 Wuertz KM, Barkei EK, Chen WH, Martinez EJ, Lakhal-Naouar I, Jagodzinski LL, Paquin-Proulx D, Gromowski GD, Swafford I, Ganesh A, Dong M, Zeng X, Thomas PV, Sankhala RS, Hajduczki A, et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters. Biorxiv : the Preprint Server For Biology. PMID 34159328 DOI: 10.1101/2021.06.16.448525  0.822
2021 King HAD, Gordon Joyce M, Naouar IE, Ahmed A, Cincotta CM, Subra C, Peachman KK, Hack HH, Chen RE, Thomas PV, Chen WH, Sankhala RS, Hajduczki A, Martinez EJ, Peterson CE, ... ... Paquin-Proulx D, et al. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Biorxiv : the Preprint Server For Biology. PMID 33851155 DOI: 10.1101/2021.04.09.439166  0.848
2021 Joyce MG, King HAD, Naouar IE, Ahmed A, Peachman KK, Cincotta CM, Subra C, Chen RE, Thomas PV, Chen WH, Sankhala RS, Hajduczki A, Martinez EJ, Peterson CE, Chang WC, ... ... Paquin-Proulx D, et al. Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates. Biorxiv : the Preprint Server For Biology. PMID 33791694 DOI: 10.1101/2021.03.24.436523  0.831
2021 Mdluli T, Jian N, Slike B, Paquin-Proulx D, Donofrio G, Alrubayyi A, Gift S, Grande R, Bryson M, Lee A, Dussupt V, Mendez-Rivera L, Sanders-Buell E, Chenine AL, Tran U, et al. Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses. Plos Pathogens. 17: e1009386. PMID 33651828 DOI: 10.1371/journal.ppat.1009386  0.408
2021 Silva de Castro I, Gorini G, Mason R, Gorman J, Bissa M, Rahman MA, Arakelyan A, Kalisz I, Whitney S, Becerra-Flores M, Ni E, Peachman K, Trinh HV, Read M, Liu MH, ... ... Paquin-Proulx D, et al. Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates. Iscience. 24: 102047. PMID 33554060 DOI: 10.1016/j.isci.2021.102047  0.417
2020 Mdluli T, Jian N, Slike B, Paquin-Proulx D, Donofrio G, Alrubayyi A, Gift S, Grande R, Bryson M, Lee A, Dussupt V, Mendez-Riveria L, Sanders-Buell E, Chenine AL, Tran U, et al. RV144 HIV-1 vaccination impacts post-infection antibody responses. Plos Pathogens. 16: e1009101. PMID 33290394 DOI: 10.1371/journal.ppat.1009101  0.54
2020 Om K, Paquin-Proulx D, Montero M, Peachman K, Shen X, Wieczorek L, Beck Z, Weiner JA, Kim D, Li Y, Mdluli T, Shubin Z, Bryant C, Sharma V, Tokarev A, et al. Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge. Plos Pathogens. 16: e1008764. PMID 32881968 DOI: 10.1371/Journal.Ppat.1008764  0.581
2020 Karch CP, Paquin-Proulx D, Eller MA, Matyas GR, Burkhard P, Beck Z. Impact of the expression system on the immune responses to self-assembling protein nanoparticles (SAPNs) displaying HIV-1 V1V2 loop. Nanomedicine : Nanotechnology, Biology, and Medicine. 102255. PMID 32615339 DOI: 10.1016/j.nano.2020.102255  0.42
2020 Colby DJ, Sarnecki M, Barouch DH, Tipsuk S, Stieh DJ, Kroon E, Schuetz A, Intasan J, Sacdalan C, Pinyakorn S, Grandin P, Song H, Tovanabutra S, Shubin Z, Kim D, ... Paquin-Proulx D, et al. Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption. Nature Medicine. PMID 32235883 DOI: 10.1038/s41591-020-0774-y  0.393
Show low-probability matches.